Feed PROGEN.ST
PR
Prostatype Genomics AB (publ)
PROGEN.ST · STO
0.11 kr +3.37% (+0.00 kr)
1M -42.22%
Market Cap 3.43M kr
P/E Ratio -
Div. Yield -
ROE 141.25%
Bulios Fair Price
0.14 kr
30.2% upside
Preț actual
0.11 kr
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile PROGEN.ST sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Piotroski F-Score Weak
1/9Valuation
63 /100
Fair P/B 0.13x
P/S 5.78x
EV/FFO N/A
Growth
6 /100
Declining Book val. growth 0.48%
Rev. growth 4.55%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 6,555.22%
Gross margin 3,401.35%
FCF margin 4,050.34%
Quality
0 /100
Poor ROA 87.50%
ROIC 122.34%
Asset turnover 0.01x
Debt
47 /100
Moderate Int. coverage -171.53x
Debt/Equity 0.20x
Current ratio 0.44x
Stability
13 /100
Unstable EPS volatility 75.27%
Beta 1.41x
Profitable years 0
Întreabă StockBot despre PROGEN.ST
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Fredrik Rickman
Employees
7
Headquarters
Nacka Strand